IPHARMA is a well-established CRO that manages clinical trials in Russia and EAEU. Clinical branch of ChemRar group, and partner of Skolkovo Innovative center.
Pharmaceutical and biotech companies usually have a wide choice of proposals from CROs. We understand the needs of different companies from pharmaceutical giants to smaller biotech startups, and we try to be flexible and efficient to meet their expectations.
Advantages of working with IPHARMA:
Leading positions on the market of Russian innovative drugs according to ACTO analytical report for 2013 - 2020.
Opportunities for drug localization, investments, and market access.
Full cycle of drug development: formulation, batches, QC, preclinical, clinical.
Medical and PV expertise with access to top scientists and KOLs.
Quality management systems and experienced staff.